Tübingen-based SHS Capital has raised €270 million for their sixth fund generation. The investment focus of the new fund SHS VI is on growing European healthcare companies. The new fund aims for ten to fifteen investments in the form of both majority and minority positions. The fund’s investment amount is €10 to €40 million. Together with LPs and other investors, transaction values of up to €150 million can be realized.
SHS only invests in companies already generating significant revenues that are on a growth path, and aim to become European healthcare champions. SHS can support this through its large network in the healthcare sector, its long-standing industry experience, and extensive market knowledge.
“The volume of the new fund has significantly exceeded our expectations and confirmed our positioning as the leading private equity healthcare specialist in Germany, and thus the largest European healthcare market. We are very pleased that many of SHS’s investors in previous funds have also invested in our new fund, in some cases with significantly increased subscriptions. In addition, we were able to further internationalize our pool of investors and expand it with renowned addresses. We would like to thank our investors for their trust,” said SHS Managing Partner Sascha Alilovic.
Since the first closing of the fund last summer, four investments have already been made. SHS has realized a total of 13 investments and 13 exits since 2020. Amongst the investors of SHS VI are fund of funds, insurance companies, pension funds, foundations, family offices, banks, healthcare corporates, church investors, and entrepreneurs. Furthermore, the SHS investment team itself has invested significantly.
“The healthcare sector is an indispensable sector and therefore offers numerous exciting opportunities for investments. With us, investors have the chance to participate in the development of this growth market. Our track record shows attractive returns for our investors and at the same time contribute to improving the healthcare system through innovations and optimizing patient care,” explained Manfred Ulmer-Weber, Managing Partner at SHS.
SHS Capital is a private equity provider founded in 1993 that invests in healthcare companies in Europe. The focus of the investments is on expansion financing, shareholder changes and succession situations. In its investment decisions, SHS attaches great importance to the consideration of ESG aspects and has therefore committed itself to the guidelines of the UN PRI.
